Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN Cause Insurance issue? 49 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Insurance issue have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.1% of all adverse event reports for ROSUVASTATIN.

49
Reports of Insurance issue with ROSUVASTATIN
0.1%
of all ROSUVASTATIN reports
1
Deaths
8
Hospitalizations

How Dangerous Is Insurance issue From ROSUVASTATIN?

Of the 49 reports, 1 (2.0%) resulted in death, 8 (16.3%) required hospitalization, and 1 (2.0%) were considered life-threatening.

Is Insurance issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 49 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN Cause?

Myalgia (3,958) Dyspnoea (2,832) Pain (2,758) Drug ineffective (2,347) Fatigue (2,208) Rhabdomyolysis (2,173) Arthralgia (1,879) Asthma (1,843) Muscle spasms (1,843) Pain in extremity (1,686)

What Other Drugs Cause Insurance issue?

CERTOLIZUMAB PEGOL (1,210) HUMAN IMMUNOGLOBULIN G (1,090) LISDEXAMFETAMINE DIMESYLATE (590) RIFAXIMIN (577) LENALIDOMIDE (376) ARIPIPRAZOLE (345) HUMAN C1-ESTERASE INHIBITOR (295) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (253) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (227) ETANERCEPT (220)

Which ROSUVASTATIN Alternatives Have Lower Insurance issue Risk?

ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN vs ROXICODONE ROSUVASTATIN vs ROXITHROMYCIN

Related Pages

ROSUVASTATIN Full Profile All Insurance issue Reports All Drugs Causing Insurance issue ROSUVASTATIN Demographics